Skip to content

Clinical trials

Withdrawn Phase 2 Hematologic Diseases trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hematologic Diseases Phase: Phase 2 Status: Withdrawn Clear all

6 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20072
20202
20211
20221

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Withdrawn6

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
University of Cincinnati2
Baptist Health South Florida1
Canadian Myeloma Research Group1
Kezar Life Sciences, Inc.1
M.D. Anderson Cancer Center1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hematologic Diseases6
Hematologic Neoplasms2
Leukemia, Myelogenous, Chronic, BCR-ABL Positive2
Leukemia, Myeloid, Acute2
Anemia1
Anemia, Hemolytic, Autoimmune1
Blast Crisis1
Cardiovascular Diseases1
Hemolysis1
Immune System Diseases1

Trials

Showing 1 to 6 of 6. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.